secwatch.observer — SEC 8-K summary
======================================

Issuer:     MeiraGTx Holdings plc (MGTX)
CIK:        0001735438
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001104659-26-048196
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MeiraGTx closes initial $200M Hologen collaboration; Hologen to own 70% of neuro JV
--------------------------------------------------------------------------------

- Completed initial closing of strategic collaboration with Hologen on April 20, 2026; Hologen provided $200M upfront cash payment.
- Hologen to fund remaining portion of upfront via post-completion share purchases, ultimately owning 70% of HNAI and minority stake in MeiraGTx Manufacturing.
- Collaboration covers AAV-GAD for Parkinson's disease, AAV-BDNF for genetic obesity disorders, and proprietary CNS delivery device.
- MeiraGTx Neuro UK retains 30% of HNAI; Hologen gets exclusive option to buy up to 40% of MeiraGTx Manufacturing shares within 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1735438/000110465926048196/0001104659-26-048196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1735438/000110465926048196/mgtx-20260420x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-048196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer